When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Last reviewed: 15 Mar 2025
Last updated: 04 Jul 2023

Summary

Definition

History and exam

Key diagnostic factors

  • severe sudden-onset headache
  • depressed consciousness/loss of consciousness
  • neck stiffness and muscle aches (meningismus)
  • risk factors
  • eyelid drooping, diplopia with mydriasis, orbital pain

Other diagnostic factors

  • photophobia
  • nausea/vomiting
  • confusion
  • history of sentinel headaches
  • seizures
  • diplopia
  • visual loss
  • agitation
  • focal neurological deficits

Risk factors

  • hypertension
  • smoking
  • family history
  • autosomal dominant polycystic kidney disease (ADPKD)
  • alcohol use
  • cocaine use
  • Marfan syndrome
  • Ehlers-Danlos syndrome
  • pseudoxanthoma elasticum
  • neurofibromatosis type I

Diagnostic investigations

1st investigations to order

  • non-contrast CT head
  • FBC
  • serum electrolytes
  • clotting profile
  • troponin I
  • serum glucose
  • ECG

Investigations to consider

  • lumbar puncture (LP)
  • computed tomography angiography (CTA)
  • digital subtraction angiography (DSA) or magnetic resonance angiography (MRA)
  • electroencephalogram (EEG)

Treatment algorithm

Contributors

Expert advisers

Matthew Jones

Consultant Neurologist

Greater Manchester Neurosciences Centre

Salford Royal Foundation Trust

Honorary Senior Lecturer

University of Manchester

Manchester

UK

Disclosures

MJ is the chair of the Association of British Neurologists Education Committee (unpaid position). MJ is a faculty member of an MRCP revision course. MJ has received honoraria from Eisai for educational talks.

Rachael Power, MBChB, MRCP

Neurology Registrar

Manchester Centre for Clinical Neurosciences

Manchester

UK

Disclosures

RP declares that she has no competing interests.

Acknowledgements

BMJ Best Practice would like to gratefully acknowledge the previous expert contributor, whose work has been retained in parts of the content:

Salah Keyrouz MD, FAHA

Associate Professor

Neurology and Neurosurgery

Washington University School of Medicine

St. Louis

MO

Disclosures

SK is an author of a reference cited in this topic.

Peer reviewers

Tim Harris

Professor of Emergency Medicine

Barts Health NHS Trust

London

UK

Disclosures

Diederik Bulters

Consultant Neurosurgeon

University Hospital Southampton NHS Foundation Trust

Southampton

Hampshire

UK

Disclosures

DB is the chief investigator for the 'SFX-01 after SAH' trial sponsored by Evgen Pharma. He receives no payment from and has no financial interest in Evgen Pharma.

Nicholas Borg

Registrar

University Hospital Southampton NHS Foundation Trust

Southampton

Hampshire

UK

Disclosures

NB declares that he has no competing interests.

Use of this content is subject to our disclaimer